Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,611 across all filing types
Latest filing 2023-12-13 Investor Presentation
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
112年12月法人說明會簡報 — 173420231213M001.pdf
Investor Presentation Classification · 95% confidence The document is titled '杏輝藥品工業股份有限公司 112年法人說明會' which translates to 'Annual Corporate Presentation 112 Year' (112 corresponds to the year in the Taiwanese calendar, roughly 2023). The content includes detailed company information such as business directions, operational overview, financial summary with revenue and net profit figures for the first three quarters of the year, ESG (Environmental, Social, Governance) highlights, social contributions, product development, and market expansion. It also includes management names and dates, and a Q&A section at the end. The document is a detailed presentation aimed at investors and stakeholders, covering financials, strategy, market position, and outlook. It is not a full annual report or audit report, nor is it a brief earnings release or a voting result announcement. The presence of slides, pictures, and structured sections typical of a corporate presentation further supports this. Therefore, the document best fits the category of an Investor Presentation (IP). The document length (over 14,000 characters) and detailed content confirm it is the presentation itself, not just an announcement or summary.
2023-12-13 Chinese
112年12月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a scheduled investor presentation (法人說明會) including date, time, location, and links to presentation materials and video. It is not a full report but rather information about an investor presentation event and related materials. The presence of presentation PDFs and video links aligns with an Investor Presentation filing. The document length is short and it does not contain financial statements or detailed analysis, so it is not an Annual Report or Interim Report. Therefore, the best classification is Investor Presentation (IP).
2023-12-13 Chinese
本公司受邀參加國票綜合證券舉辦之法人說明會
Regulatory Filings Classification · 90% confidence The document is a short announcement about the company (1734 杏輝) being invited to participate in an investor presentation (法人說明會) organized by a securities firm. It provides details about the date, time, and location of the event and mentions that the company will explain its operational overview and business-related information. The document does not contain actual financial statements or detailed financial data, nor does it include a transcript or report. It is essentially a notice of an upcoming investor presentation event. Given the length (663 characters) and content, this fits the category of an Investor Presentation (IP) announcement rather than the presentation materials themselves. However, since the document is announcing the event and not providing the presentation materials, it is best classified as Regulatory Filings (RNS) because it is a general regulatory announcement about the event without the actual presentation content.
2023-12-11 Chinese
112年11月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (杏輝) providing information on fund lending balances and endorsement guarantees for the current and previous month. It contains tabular data on financial guarantees and limits but does not include comprehensive financial statements or detailed analysis. The document length is very short (629 characters), and it appears to be a regulatory disclosure or compliance update rather than a full financial report or announcement of a meeting or vote. There is no indication of an annual or interim report, earnings release, or management discussion. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement providing specific financial data without constituting a full report or presentation.
2023-12-08 Chinese
112年11月營業收入
Interim / Quarterly Report Classification · 90% confidence The document is a summary report of monthly and cumulative revenue figures for a company named 杏輝, presented in a tabular format with explanations about accounting standards and reporting practices. It contains actual financial data for a specific month and year (民國112年11月, which corresponds to 2023 November). The content is substantive financial data rather than a brief announcement or a certification. The document length is short (770 characters), but it includes detailed financial figures and explanations, indicating it is a financial report for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-12-08 Chinese
112年11月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, chairpersons, general managers, and their family members. It shows changes in shareholdings, types of shares held, and other related data. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of it being a full annual or quarterly report, earnings release, or any other report type. The document is not a brief announcement but a detailed disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is substantive insider shareholding data, not a mere announcement or certification. Therefore, the correct classification is DIRS with high confidence.
2023-12-06 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.